Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endologix Inc (NASDAQ:ELGX)

4.73
Delayed Data
As of May 26
 -0.05 / -1.05%
Today’s Change
4.21
Today|||52-Week Range
14.50
-17.31%
Year-to-Date
No recent news for Endologix Inc.

Today’s Trading

Previous close4.78
Today’s open4.80
Day’s range4.70 - 4.80
Volume583,608
Average volume (3 months)1,627,721
Market cap$392.5M
Dividend yield--
Data as of 3:59pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)-154.67%
Earnings growth (this year)+18.99%
Earnings growth (next 5 years)+95.60%
Revenue growth (last year)+25.59%
P/E ratioNM
Price/Sales2.40
Price/Book3.47

Competitors

 Today’s
change
Today’s
% change
TCMDTactile Systems Tech...+0.23+1.00%
ATRSAntares Pharma Inc-0.04-1.57%
ELOSSyneron Medical Ltd-0.05-0.46%
RMTIRockwell Medical Inc-0.15-2.01%
Data as of 3:59pm ET, 05/26/2017

Financials

Next reporting dateAugust 1, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$192.9M
Annual profit (last year)-$154.7M
Net profit margin-80.17%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Executive Officer &
Director
John D. McDermott
President
Robert D. Mitchell
Corporate headquarters
Irvine, California

Forecasts